Funds to support pipeline development and commercial operations
BOSTON, MA – February 1, 2018/ PR Newswire/
Partner Therapeutics, Inc. (PTx) announced today the closing of a Series A financing to support the launch and growth of the company. PTx is an oncology company focused on the development and commercialization of approved and late-stage therapies that improve treatment outcomes and reduce the total cost of care.
The financing totaled $60 million and was led by a group of pre-eminent biopharma investors, including Perceptive Advisors, ...
Continue Reading →
1
FEB
2018
FEB
2018
0